Neuro-Oncology

Description

Volume

Issue

NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat

Amedeo A Azizi, David A Walker, Jo-Fen Liu, Astrid Sehested, Timothy Jaspan, Berthold Pemp, Ian Simmons, Rosalie Ferner, Jacques Grill, Darren Hargrave, Pablo Hernáiz Driever, D Gareth Evans, Enrico Opocher

Publication Date: 2020-07-06T00:00

research-article Pages: 11

$Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma$

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Junsaku Kitagawa, Arata Aoi, Ryo Nishikawa

Publication Date: 2020-06-25T00:00

research-article Pages: 11